These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 17298481)
1. Pharmacogenetic interactions of three candidate gene polymorphisms with ACE-inhibitors or beta-blockers and the risk of atherosclerosis. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Br J Clin Pharmacol; 2007 Jul; 64(1):57-66. PubMed ID: 17298481 [TBL] [Abstract][Full Text] [Related]
2. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437 [TBL] [Abstract][Full Text] [Related]
3. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011 [TBL] [Abstract][Full Text] [Related]
4. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke. Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611 [TBL] [Abstract][Full Text] [Related]
5. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550 [TBL] [Abstract][Full Text] [Related]
6. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives. Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171 [TBL] [Abstract][Full Text] [Related]
7. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene. Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286 [TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes. Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258 [TBL] [Abstract][Full Text] [Related]
10. Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Schelleman H; Stricker BH; Verschuren WM; de Boer A; Kroon AA; de Leeuw PW; Kromhout D; Klungel OH Pharmacogenomics J; 2006; 6(1):22-6. PubMed ID: 16314886 [TBL] [Abstract][Full Text] [Related]
11. Antihypertensive medications and risk of community-acquired pneumonia. Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911 [TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study. Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807 [TBL] [Abstract][Full Text] [Related]
13. Gene polymorphisms of the renin-angiotensin system and early development of hypertension. Barbalić M; Skarić-Jurić T; Cambien F; Barbaux S; Poirier O; Turek S; Vrhovski-Hebrang D; Cubrilo-Turek M; Rudan I; Rudan P; Narancić NS Am J Hypertens; 2006 Aug; 19(8):837-42. PubMed ID: 16876684 [TBL] [Abstract][Full Text] [Related]
14. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. van den Born BJ; van Montfrans GA; Uitterlinden AG; Zwinderman AH; Koopmans RP J Hypertens; 2007 Nov; 25(11):2227-33. PubMed ID: 17921816 [TBL] [Abstract][Full Text] [Related]
15. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Bautista LE; Vargas CI; Oróstegui M; Gamarra G Hypertens Res; 2008 Mar; 31(3):401-8. PubMed ID: 18497458 [TBL] [Abstract][Full Text] [Related]
16. Gene polymorphisms of the renin-angiotensin-aldosterone system and essential arterial hypertension in childhood. Petrovic D; Bidovec M; Peterlin B Folia Biol (Krakow); 2002; 50(1-2):53-6. PubMed ID: 12597535 [TBL] [Abstract][Full Text] [Related]
17. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury]. Lu LH; Chen H; Yu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230 [TBL] [Abstract][Full Text] [Related]
18. Interaction between GNB3 C825T and ACE I/D polymorphisms in essential hypertension in Koreans. Bae Y; Park C; Han J; Hong YJ; Song HH; Shin ES; Lee JE; Han BG; Jang Y; Shin DJ; Yoon SK J Hum Hypertens; 2007 Feb; 21(2):159-66. PubMed ID: 17066084 [TBL] [Abstract][Full Text] [Related]
19. Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system. Tabara Y; Kohara K; Nakura J; Miki T J Hum Genet; 2001; 46(5):278-84. PubMed ID: 11355019 [TBL] [Abstract][Full Text] [Related]
20. The relationship between antihypertensive combination therapies comprising diuretics and/or beta-blockers and the risk of new-onset diabetes: a retrospective longitudinal cohort study. Liou YS; Ma T; Tien L; Lin CM; Jong GP Hypertens Res; 2009 Jun; 32(6):496-9. PubMed ID: 19390541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]